baber/WOPTO huggingface dataset:
Patent ES-2231395-T3 (ES)
Title: Nuevas bases de oxidacion con cadena guanidina,su procedimiento de preparacion, su utilizacion para el teñido por oxidacion de las fibras queratinicas, composiciones tintoriales y procedimientos de teñido.
Inventor: BORDIER THIERRY
IPC: C07C281/18
Filed: 2001-01-16
Granted: 2005-05-16
Abstract: Compuestos de fórmula (I) siguiente, y sus sales de adición con un ácido: **(Fórmula)** en la cual: - X1 y X2 representan un radical hidroxilo, un radical -NHR1 o -NR1R2, entendiéndose que X1 y X2 no pueden representar simultáneamente un radical hidroxilo; - R1 y R2, idénticos o diferentes, representan un átomo de hidrógeno, un radical alquilo de C1-C8, monohidroxialquilo de C1-C8, polihidroxialquilo de C2-C8, aminoalquilo de C2-C8, monoalquil(C1-C4)aminoalquilo de C1-C4, dialquil(C1-C4)aminoalquilo de C1-C4, o halogenoalquilo de C1-C8; cuando X1 y/o X2representa(n) un radical -NR1R2, entonces R1 y R2 pueden igualmente formar juntos, con el átomo de nitrógeno al cual están unidos, un ciclo con 4, 5 ó 6 eslabones, aromático o no; -R1 y R2, independientemente el uno del otro, pueden igualmente representar un ciclo con 4, 5 ó 6 eslabones, aromático o no, pudiendo incluir el indicado ciclo uno o varios heteroátomos; - A representa un radical divalente seleccionado entre CH=N y CH 2NH; y -CH2-NH- Z representa un átomo de hidrógeno, un átomo de halógeno, un ciclo aromático o no con 4, 5 ó 6 eslabones, un radical alquilo de C1-C8, monohidroxialquilo de C1-C8, polihidroxialquilo de C2-C8, aminoalquilo de C2-C8, monoalquil (C1-C4)aminoalquilo de C1-C4, dialquil(C1-C4)aminoalquilo de C1-C4 o halogenoalquilo de C1-C8, ciano, o un grupo -BR3 en el cual B representa un radical divalente seleccionado entre los radicales siguientes: **(Fórmulas)** y en el cual R3 representa un radical alquilo de C1-C8, monohidroxialquilo de C1-C8, polihidroxialquilo de C2-C8, aminoalquilo de C2-C8, monoalquil(C1-C4)aminoalquilo de C1-C4, dialquil(C1-C4)aminoalquilo de C1-C4, o halogenoalquilo de C1-C8.
Patent ES-2360931-T3 (ES)
Title: Dispositivo para la implantación encastrada de al menos un aparato eléctrico en un conducto de cableado de profundidad inferior a la del aparato.
Inventor: COUTANT REGIS
IPC: H02G3/12
Filed: 2001-08-29
Granted: 2011-06-10
Abstract: Dispositivo para la implantación empotrada de al menos un aparato eléctrico (100) en un conducto de cableado (110) de profundidad (p) inferior a la (P) del aparato, que comprende - al menos un soporte (1) provisto de medios para su fijación al conducto y de medios de recepción (3) del aparato eléctrico (100) de tal manera que la cara delantera de este aparato queda a haces con la cara delantera (32, 116) del conducto (110) a través de una abertura (31) practicada en correspondencia en esta última, y - al menos una caja de reserva dispuesta de manera que atraviesa una abertura (119) practicada en correspondencia en el fondo (42) de este conducto y que forma en este último un hueco de acogida de la parte trasera del aparato (100), caracterizado porque la caja de reserva (20) está realizada en forma de una pieza distinta del soporte, que tiene sus propios medios (25, 26) de fijación al conducto (110).
Patent ES-2248272-T3 (ES)
Title: Formulacion de fulvestrant.
Inventor: EVANS JOHN RAYMOND
IPC: A61K36/47
Filed: 2001-01-08
Granted: 2006-03-16
Abstract: Una formulación farmacéutica que comprende fulvestrant en un vehículo de ricinoleato, un disolvente no acuoso de tipo éster farmacéuticamente aceptable, y un alcohol farmacéuticamente aceptable, en la que la formulación está adaptada para la administración por vía intramuscular, y que logra una concentración terapéuticamente significativa de fulvestrant en plasma sanguíneo durante al menos dos semanas.
Patent ES-2247066-T3 (ES)
Title: Absorbentes de uv benzotriazol resistente a la eflorescencia y composiciones estabilizadas con estos absorbedores.
Inventor: WOOD MERVIN GALE
IPC: C07D249/20
Filed: 2001-01-23
Granted: 2006-03-01
Abstract: Un compuesto de **fórmula**, en donde G1 y G2'' son independientemente hidrógeno o halógeno, G2 y G2'' son independientemente hidrógeno, halógeno, nitro, ciano, E3SO-, E3SO2-, -COOG3, perfluoroalquilo de 1 a 12 átomos de carbono, -P(O)(C6H5)2, -CO-G3, -CO-NH-G3, -CO- N(G3)2, -N(G3)-CO-G3, G3 es hidrógeno, alquilo de cadena lineal o ramificada de 1 a 24 átomos de carbono, alquenilo de cadena lineal o ramificada de 2 a 18 átomos de carbono, cicloalquilo de 5 a 12 átomos de carbono, fenilalquilo de 7 a 15 átomos de carbono, fenilo, o dicho fenilo o dicho fenilalquilo sustituido en el anillo de fenilo por 1 a 4 átomos de carbono.
Patent ES-2282238-T3 (ES)
Title: Anticuerpos monoclonales contra el receptor ldl humano, su produccion y uso.
Inventor: YONAH NACHUM
IPC: C12N/
Filed: 2001-03-08
Granted: 2007-10-16
Abstract: Un anticuerpo monoclonal, anticuerpo quimérico, anticuerpo totalmente humanizado, anticuerpo anti-anti-ID o sus fragmentos, que reconocen específicamente y se unen al receptor de LDL humano soluble y sus fragmentos, que es capaz de inhibir la replicación del virus de la hepatitis C, y que es asequible inmunizando animales con LDLR +291 humano soluble, es decir, la forma del receptor humana soluble incluyendo la forma de la secuencia de aminoacios de Asp+4 a Glu+291 de la secuencia de LDLR humano soluble, excepto el anticuerpo monoclonal C7.
Patent ES-2306708-T3 (ES)
Title: Aditivo de acelerador-gel para su utilizacion en la produccion de asfalto modificado por polimero.
Inventor: BAUMGARDNER GAYLON L
IPC: C09K3/00
Filed: 2001-03-12
Granted: 2008-11-16
Abstract: Utilización de un aditivo de acelerador-gel que comprende: A. un gel que incluye: i. un aceite de tratamiento, ii. una arcilla organofílica, y iii. un activador polar que es seleccionado de entre el grupo constituido por carbonato de propileno y una mezcla etanol-agua; y B. un acelerador que mejora la unión y el endurecimiento del polímero y el asfalto, estando dicho acelerador suspendido dentro del gel, en la producción de una composición que contiene asfalto modificado por polímero.
Patent ES-2303832-T3 (ES)
Inventor: OKU KINUKO
IPC: A61K9/00
Filed: 2001-06-05
Granted: 2008-09-01
Abstract: Optimum compounding composition of a local injection preparation for treating rectal submucous lesioned abnormal tissue with local anesthetic is decided to provide a medical composition kit. In a composition kit for the treatment where respective containers are unsealed upon being used and respective contents are mixed to obtain a preparation for injection, a medical composition kit which is characterized in that respective single doses of a therapeutic preparation and local anesthetic are fractionally charged in containers, the said therapeutic preparation contains 1 SIMILAR 10% of a water-soluble aluminum compound and 0.01 SIMILAR 2% of tannic acid and the said local anesthetic contains 0.1 SIMILAR 1% of lidocaine hydrochloride or 0.5 SIMILAR 5% of procaine hydrochloride.
Patent ES-2294034-T3 (ES)
Title: Producto y procedimiento para la limpieza de superficies de titanio.
Inventor: CANO IRANZO FRANCISCO
IPC: C11D3/08
Filed: 2001-10-24
Granted: 2008-04-01
Abstract: El producto limpiador comprende, por separado, (A) una composición reveladora que comprende una mezcla de ácido nítrico y ácido fluorhídrico, un espesante, un tensioactivo, un indicador, agua, y, opcionalmente, un propelente; y (B) una composición fijadora que comprende una base, un espesante, un tensioactivo, agua, y un propelente. Dicho producto limpiador es útil para la limpieza de superficies de titanio, tales como fachadas y paneles de titanio.
Patent ES-2239682-T3 (ES)
Inventor: NUNEZ BENITO ANA
IPC: G06Q20/00
Filed: 2001-10-26
Granted: 2005-10-01
Abstract: Starting from a purchase system wherein the holder of a mobile phone comes to an agreement with a financial company which provides him with a paycard to which he can subsequently charge his purchases, in such a manner that in each purchase he should provide his telephone number so that they may validate the operation in a processing centre contacting the user by phone to ask for the payment authorisation after identification of the user by a secret code, the invention consists of using a new card (1), with the classic sixteen digits, where the first four (2) correspond to the specific BIN of the processing company, the nine following ones (3) to the user's mobile phone number and the last digit (4) consists of a control digit for the 15 previous ones, as in any conventional paycard. In this manner, on supplying the client physically with the card, or its data through Internet, the mobile phone number is inadvertently being supplied to be able to validate the operation by telephone. <IMAGE>
Patent ES-2195801-T3 (ES)
Inventor: MCGILL GARY SHANE
IPC: A23G9/50
Filed: 1993-12-16
Granted: 2005-06-16
Abstract: Viscous or semi-solid food is dispensed by sealing a portion of it into a correspondingly sized container (10), which has a deformable part (17,18), and supporting (25) the container while a plunger (29) deforms the container part (17,18) so as to discharge the food through an outlet (22) to a suitable sized receptacle (12) below the outlet. Also claimed is a deformable container having an outlet for dispensing viscous or semi-solid foods. Also claimed is a system for dispensing such foods, having a deformable container and a drive for a plunger engageable with the container to deform it and discharge the food.
Patent ES-2288176-T3 (ES)
Inventor: SONOBE NAOHIRO
IPC: C01B32/336
Filed: 2002-04-09
Granted: 2008-01-01
Abstract: An adsorbent (A) comprises a porous spherical carbonaceous substance. The diameter of (A) is (0.01 - 1, preferably 0.02 - 0.8) mm, specific surface area (at least 700, preferably 700 - 2500) m 2>/g determined by BET method, volume of pores (0.04 - =0.1) ml/g having pore diameter (20 - 15000) nm, total amount of acidic groups (0.3 - 1.2) meq/g and total amount of basic group (0.2 - 0.7) meq/g. An independent claim is included for a pharmaceutical composition comprising (A) and a carrier or diluent. ACTIVITY : Nephrotropic; Hepatotropic; Gastrointestinal. An absorbent (3 g/day) was orally administered to a male patient (79 years) suffering from liver dysfunction showed GOT (glutamic-oxaloacetic transaminase) (47 units) and GPT (glutamic-pyruvic transaminase) (66 units). Four months later GOT was lowered to 21 units and GPT was lowered to 24 units. The administration was continued and after 7 months the GOT was lowered to 18 units and GPT was lowered to 21 units. MECHANISM OF ACTION : None given.
Patent ES-2229014-T3 (ES)
Inventor: RICCO MARIO
IPC: F02M61/16
Filed: 2002-06-04
Granted: 2005-04-16
Abstract: An internal combustion engine fuel injector (1; 51) has a casing (2) defining a nozzle (7); and a shutter pin (16) having an axis (19), and housed in axially sliding manner inside the casing (2) to close the nozzle (7) by virtue of a control rod (23). The pin (16) and the control rod (23) are connected by a connecting device (35; 55), which has an axial seat (36) carried by the pin (16), and a head (39; 59; 69) interposed between the axial seat (36) and the control rod (23), and which engages the axial seat (36) to transmit to the pin (16) a resultant of forces (A) directed solely along the pin axis (19). <IMAGE>
Patent ES-2303841-T3 (ES)
Inventor: TANAKA NAYOSHI
IPC: B67C3/28
Filed: 2002-07-09
Granted: 2008-09-01
Abstract: A rotary and flow meter type liquid filling apparatus including a liquid reservoir tank (46) that stores and supplies liquid to filling nozzles, and air supply paths for different amount of air supply and air discharge paths for different amount of air discharge being connected to the liquid reservoir tank. An air compressor is connected to the air supply paths, and the air discharge paths open into the atmosphere. A liquid pressure sensor (43) disposed near the filling nozzles sense the increase or decrease of the liquid pressure inside a pipe that connects the liquid reservoir tank (46) and liquid filling nozzles (21), and the electromagnetic valves (51, 52) provided on the air supply and air discharge paths are opened or closed, thus supplying air to and discharging air from the liquid reservoir tank (46) so as to control the air pressure inside the liquid reservoir tank (46) and the liquid pressure near the liquid filling nozzles. <IMAGE>
Patent ES-2321483-T3 (ES)
Inventor: BALLSIEPER BARBARA
IPC: G21F3/02
Filed: 2002-11-20
Granted: 2009-06-08
Abstract: The complementary Velcro (RTM) fastener parts (4a,4b) are positioned on the garment (1), such that they are placed on top of each other to create an adhesive contact for the fastening of the garment. At least one of the complementary parts is connected detachably to the clothing.
Patent ES-2311575-T3 (ES)
Inventor: HOLTKAMP EGBERT BEREND
IPC: B60P3/34
Filed: 2002-02-19
Granted: 2009-02-16
Abstract: A camping device for use in combination with a car with towing hook, comprising a carrier which can be mounted on a towing hook, wherein the carrier is provided with a foldable construction connected to the carrier, which foldable construction, in unfolded condition, in cooperation with at least one wall of the car, forms a camping accommodation, so that the car can be used as a camper. <IMAGE>
Patent ES-2357524-T3 (ES)
Inventor: LEFEVRE DIDIER
IPC: C12Q1/02
Filed: 2002-02-18
Granted: 2011-04-27
Abstract: The invention relates to a reagent and a process for the identification and counting of biological cells in a sample. This reagent comprises a cell lysing agent selected from at least one detergent in a concentration capable of specifically lysing a given type of cells in the sample, and a stain capable of marking the intracellular nucleic acids of the remaining unlysed cells. Application in particular for the identification and counting of cells using an automated analysis system based on flow cytometry.
Patent ES-2272720-T3 (ES)
Inventor: LIU JIE
IPC: A61K9/08
Filed: 2002-01-02
Granted: 2007-05-01
Abstract: An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed.
Patent ES-2276942-T3 (ES)
Inventor: YEADON MICHAEL
IPC: A61K9/12
Filed: 2002-05-23
Granted: 2007-07-01
Abstract: The present invention relates to a combination of therapeutic agents useful in the treatment of obstructive airways and other inflammatory diseases comprising (I) a PDEIV inhibitor that is therapeutically effective in the treatment of said diseases when administered by inhalation; together with (II) an anti-cholinergic agent comprising a member selected from the group consisting of tiotropium and derivatives thereof that is therapeutically effective in the treatment of said diseases when administered by inhalation; as well as to a method of treating said obstructive airways and other inflammatory diseases comprising administering to said mammal by inhalation a therapeutically effective amount of said combination of therapeutic agents; and a pharmaceutical composition comprising a pharmaceutically acceptable carrier together with said combination of therapeutic agents; and a package containing a pharmaceutical composition for insertion into a device capable of simultaneous or sequential delivery of said pharmaceutical composition in the form of an aerosol or dry powder dispersion to said mammal, where said device is a metered dose inhaler or a dry powder inhaler. It is preferred that said anti-cholinergic agent component be tiotropium bromide.
Patent ES-2292806-T3 (ES)
Inventor: GAO FENG
IPC: C07H7/033
Filed: 2002-07-24
Granted: 2008-03-16
Abstract: Glucoside and glucuronide derivatives of hydromorphone, dihydromorphine, and dihydroisomorphine and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroisomorphine or a pharmaceutically acceptable salt thereof, and methods for treating or preventing pain in a patient comprising administering to a patient in need thereof a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroisomorphine or a pharmaceutically acceptable salt thereof are disclosed.
Patent ES-2250710-T3 (ES)
Inventor: JAEHNE GERHARD
IPC: A61P3/04
Filed: 2002-08-17
Granted: 2006-04-16
Abstract: Embodiments of the invention relate to methods of reducing weight in mammals and for the prophylaxis or treatment of obesity comprising administration of C2-substituted indan-1-ol systems and their physiologically acceptable salts and physiologically functional derivatives. Compounds for use in the methods of the embodiments of the invention include compounds of the formula (I) in which the radicals are as defined, and their physiologically acceptable salts.
Patent ES-2274106-T3 (ES)
Inventor: FINK CYNTHIA ANNE
IPC: C07K5/06
Filed: 2002-09-20
Granted: 2007-05-16
Abstract: Compounds of the formula wherein R, R<SUB>1</SUB>-R<SUB>7 </SUB>and alk have meaning as defined, pharmaceutical compositions thereof, and use thereof for the treatment and/or prevention of cardiovascular disorders responsive to ACE and NEP inhibition and/or ECE inhibition.
Patent ES-2452540-T3 (ES)
Title: Derivados de retinol, su uso en el tratamiento del cáncer y para potenciar la eficacia de otros agentes citotóxicos
Inventor: STRELCHENOK OLEG
IPC: A61K31/185
Filed: 2002-11-15
Granted: 2014-04-01
Abstract: Compuesto que tiene la fórmula estructural **Fórmula** en las que R1 se elige de **Fórmula** y R2 se elige de NH2, NHCH3, N(CH3)2 u OX en el que X es un alquilo C1-C4.
Patent ES-2262872-T3 (ES)
Inventor: VANDERVEEN TIMOTHY W
IPC: G16H70/40
Filed: 2002-12-06
Granted: 2006-12-01
Abstract: A patient care system (90) comprising an interface unit (100), an infusion pump unit (150a), and a capnography unit (150b) is disclosed. The infusion pump unit (150a) is used to administer medical fluids to a patient, including the administration of anesthethics, analgesics, or sedatives. The capnography unit (150b) provides monitoring of the patient's expired air, in particular, the end tidal CO 2  levels in the expired air and the respiration rate. When the capnography unit (150b) indicates to the interface unit that the end tidal CO 2  level and/or pulse rate has reached a point outside a specified range, the interface unit (100) initiates visual and audio alarms and controls the infusion pump unit (150a) by modifying the flow or by shutting off the pump unit. In patient controlled analgesia applications, the interface unit (100) may block patient-controlled bolus doses of the analgesic until reset by a qualified medical professional or until the measured capnography values return to a normal range. The interface unit (100) also contains communication ports, which the interface unit can use to send signals to external devices, such as to alert medical personnel.
Patent ES-2654539-T3 (ES)
Title: Procedimiento para el aislamiento de ADN a partir de muestras biológicas
Inventor: LENZ CHRISTIAN
IPC: C12Q1/6806
Filed: 2002-09-26
Granted: 2018-02-14
Abstract: Procedimiento para el aislamiento de ADN, en el que una muestra biológica se mezcla con un reactivo de lisis que contiene sales de cationes monovalentes, sales de cationes bivalentes, uno o varios formadores de complejos elegidos de tetraacetato de etilendiamina, ácido etilendioxi-bis-(etilen-nitrilo)tetraacético, DTPA y Na5P3O10 y polietoxilato de octilfenol, después se separan los componentes celulares con contenido en ADN de los restantes componentes celulares, el material celular con contenido en ADN se resuspende en una disolución salina, conteniendo la disolución salina al menos una sal caotrópica, eventualmente componentes contaminantes se separan mediante un tratamiento químico, térmico y/o enzimático, el ADN se precipita, lava, seca y eventualmente se resuspende en una disolución baja en sales, llevándose a cabo el aislamiento en un recipiente de reacción.
Patent ES-2422329-T3 (ES)
Title: Método para fabricar pasta química que contiene una carga
Inventor: SILENIUS PETRI
IPC: D21C9/00
Filed: 2002-10-23
Granted: 2013-09-10
Abstract: Método para fabricar pasta química que contiene una carga, caracterizado porque la carga se preparaprecipitando una sal que dispersa la luz seleccionada entre carbonato cálcico, yeso, oxalato cálcico, sulfato de bario,sílice precipitada, silicato y combinaciones de las mismas sobre la superficie de fibrillas de borra producidasmediante refinado a partir de fibras de celulosa y/o fibras de pasta mecánica, y la carga preparada de este modo sehace pasar en una suspensión acuosa a un secador de pasta química para mezclarla con pasta química y la pastaquímica que contiene la carga se seca.
Patent ES-2320639-T3 (ES)
Inventor: HUCHZERMEIER ROY
IPC: C12Q1/70
Filed: 2002-08-09
Granted: 2009-05-27
Abstract: The present invention relates to a method of detecting whether a target animal is Bovine Viral Diarrhea Virus (BVDV) positive or negative by determining whether a gp48 protein-specific reagent binds to a gp48 Bovine Viral Diarrhea Virus protein or protein fragment, which retains antigenic specificity, from a target animal's hair sample.
Patent ES-2227489-T3 (ES)
Inventor: GUARICCI ROMEO
IPC: A47J43/24
Filed: 2003-02-03
Granted: 2005-04-01
Abstract: The strainer (1) comprises two walls (2, 3) forming a conical chamber in the useful position. On opposite sides triangular boundary walls (13,14,15,16) are connected centrally through a hinge and to the opposite side walls through further hinges (20-25). Flat parallel holding strips (10,11) protrude from the bottom end of each one wall and in the useful position of the strainer project into parallel recesses (12) of the opposite wall.  Handle recesses (6,7) are formed in opposite walls.
Patent ES-2244877-T3 (ES)
Inventor: HESSER ROBERT
IPC: F16K31/08
Filed: 2003-10-15
Granted: 2005-12-16
Abstract: The manual operation device is for a bistable multi-path valve (2) with a switchable valve member and operating device (36) running transverse to the switching movement (7). The operating device has at least two parallel pushrods (38, 40), which acts on different flanks (19, 21) of the valve member (12) when operated. When one is in use, the other is locked.
Patent ES-2256683-T3 (ES)
Title: Configuracion de rotor de una turbomaquina.
Inventor: BRAULT MICHEL GILBERT ROLAND
IPC: F01D5/06
Filed: 2003-01-17
Granted: 2006-07-16
Abstract: Disposición de rotor que comprende una sucesión de discos (3, 4, 5, 6) portadores de álabes (10) unidos mediante separadores (7, 8, 9), comprendiendo la sucesión de discos dos discos (3, 4) en extremos opuestos de la sucesión y, al menos, un disco intermedio (5, 6), estando provistos los separadores de medios de unión (26, 27) de centrado en torno al eje de rotación del rotor y de bloqueo (31) en rotación, que cooperan con medios (28, 29, 30) de unión complementarios situados en los discos, caracterizada porque los dos discos (3, 4), en los extremos opuestos de la sucesión, están provistos de prolongaciones (17, 18) cónicas fusiformes que se unen, una con otra, mediante bridas de fijación mutua y porque el disco intermedio (5, 6) está suspendido de los separadores.